Enterprise 2.0: where to begin (part 1 – does your boss know social media?)
Posted 12th April 2011 in Articles, Commercial | Register to comment
Pharma first needs to be convinced of a few things before getting involved with social media and perhaps internal social computing is the way to convince as René van den Bos explains.
Social Media in pharma, it still is a hot topic and main subject in most of the marketing and communication conferences that I…
Read the full articleHow to use social network analysis to pinpoint more than KOLs
Posted 11th April 2011 in Articles, Commercial | Register to comment
Philip Topham discusses mapping social intelligence and scientific leadership hidden within industry networks and communities.
With Facebook boasting over half a billion members worldwide, the concept of the “social graph” has entered nearly everyone’s consciousness…
Read the full articleE-invoicing in the pharmaceutical industry
Posted 29th March 2011 in Articles, Commercial, General | Register to comment
The laborious task of invoicing can easily incur error and uses time and resources. Is it time then, Stefan Foryszewski asks, that pharma moves to e-invoicing?
For major pharmaceutical companies, the invoicing process can often be laborious. With thousands of invoices being sent to many…
Read the full articleTalent management
Posted 21st March 2011 in Articles, Commercial, General | Register to comment
Steps need to be taken in order to preserve the talent pool in pharma. Mark Holliday and co-workers expand on what we can do in this area to reduce the loss of talented individuals.
Anyone with an interest in how people are managed at work is sure to be aware of the significance that the term “talent management” has for…
Read the full articleBattling patent expiration by building brand loyalty
Posted 18th March 2011 in Articles, Commercial, General | Register to comment
As pharma faces potential losses due to patent expiration, Kelly Renfro explores how these losses could be combated by building brand loyalty.
Over the next few years, a number of blockbuster drugs face patent expiration, including Zyprexa, Xalatan, Crestor and Symbacort. It is estimated that…
Read the full articleSimple forecasts are best: easy to prove, hard to act on
Posted 16th March 2011 in Articles, Commercial, General | Register to comment
When forecasting we can often over complicate matters in the belief that complex forecasts will yield increased accuracy. Gary Johnson explains why we should keep it simple.
All good managers know that focus, clarity and simplicity are the hallmarks of good business. And yet, those same managers are …
Read the full articleMarketing rationales to avoid in 2011 (part II)
Posted 8th March 2011 in Articles, Commercial, General | Register to comment
In the second of her two part series on marketing rationales, Andree Bates gives tips on how to make rational marketing decisions.
All people, even marketers, are subject to irrationality. It’s not a question of how smart you are, but of having evolved in an environment where impulsive actions kept us alive. Hunter-gatherers who…
Read the full articleMedication packaging: an impact on patient adherence
Posted 3rd March 2011 in Articles, Commercial, General | 1 comment
The economic burden and medical complications associated with non compliance are huge. Here, Tassilo Korab discusses packaging, an aspect of non-compliance that receives little attention.
A White Paper released 2010 by the Center for Health Transformation’s 21st Century Intelligent Pharmacy Project in the US states in its introduction: Non adherence is a tremendous problem…
Read the full articleMarketing rationales to avoid in 2011 (part I)
Posted 18th February 2011 in Articles, Commercial, General | Register to comment
In the first of her two part series on marketing rationales, Andree Bates notes the irrational logic we use when justifying marketing spends.
I can’t hold my silence any longer. Too often in meetings I hear a few things uttered from pharmaceutical marketers…
Read the full articleThe analogue trap in forecasting
Posted 16th February 2011 in Articles, Commercial, General | Register to comment
Too often we’re blinded by obvious similarities between ours and another product and so then rely on this product as an analogue. Gary Johnson highlights why analogues often provide terrible forecasts.
One of the most popular approaches to forecasting is to search for a product that looks very similar to your product and then assume…
Read the full article